MORTALITY OF PREMATURELY BORN NEWBORNS WITH RESPIRATORY DISTRESS SYNDROME RECEIVED PORACTANT ALPHA

Abstract

Objective: to estimate efficiency of treatment with poractant alpha of premature newborns with respiratory distress syndrome and to define possibilities of its increase on the example of obstetrical medical centers in Azerbaijan.Materials and methods. we examined routine practice of poraktant alfa usage in premature newborns with respiratory distress syndrome during 2014-2015.Results. The general level of lethality among newborns with respiratory distress syndrome with poractant alfa herapy was 25.3%.Conclusions. The use of poractant alpha for treatment of prematurely newborns with respiratory distress syndrome allows to keep life till 74.7% of patients. There is correlation between efficiency of treatment with poraktant alfa and weight of newborn.

Keywords

• respiratory distress syndrome
• poractant alfa
• prematurity
• standardized lethality